Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis

BACKGROUND: Glucarpidase is indicated for treating delayed methotrexate (MTX) elimination due to impaired renal function. Although glucarpidase is capable of rapidly eliminating MTX independent of renal clearance, its cost can be perceived as a barrier to use. However, no published economic analyses...

Descripción completa

Detalles Bibliográficos
Autores principales: Kala, Jaya, Nelson, Rebecca, Drudge, Christopher, Zhou, Allen, Ward, Suzanne, Bourque, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008431/
https://www.ncbi.nlm.nih.gov/pubmed/36919083
http://dx.doi.org/10.2147/CEOR.S397154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008431/
https://www.ncbi.nlm.nih.gov/pubmed/36919083
http://dx.doi.org/10.2147/CEOR.S397154

Ejemplares similares